News
A circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer.
A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.
EdemaFlex, a new glove with more than three dozen actuators across all five fingers and the palm, developed by Cornell researchers, aims to reduce swelling for people suffering from edema.
The study from an international team of experts in veterinary medicine, human medicine and genomics provides the first large-scale genetic map of feline cancer.
Researchers found that higher recent dietary choline intake was associated with lower levels of inflammation in the third trimester.
The approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments.
Though pelvic floor disorders happen when the muscles and tissues that support the bladder, bowel and uterus weaken or don’t work properly, and affect one-third of all women, they are not a normal part of aging.
Gut microbes may play a key role in training a mother’s immune system to adapt to the developing fetus during pregnancy, according to a preclinical study by Weill Cornell Medicine investigators.
A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy.
Seen Nutrition won $500,000 at the state-funded Grow-NY Food and Agriculture Startup Competition.
The findings could redirect lupus research and open the door to more precise therapies that avoid broad immune suppression.
